| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |